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The use of synthetic polypeptides as immunogens has led to major insights into the 
genetic regulation of the immune response (1). In 1965, it was first demonstrated that the 
IgG  responses  to  poly-L-(Tyr,  Glu)-poly-D,L-Ala--poly-L-Lys [(T,G)-A-L]  I  and  poly-L- 
(His,Glu)-poly-D,L-Ala--poly-L-Lys [(H,G)-A-L]  were  under  autosomal dominant  ge- 
netic control in the mouse (2). By using the antigens (T,G)-A-L, (H,G)-A- L, and poly-L- 
(Phe,Glu)-poly-D,L-Ala-poly-L-Lys [(Phe,G)-A-L],  the Ir-1  locus  controlling  the  IgG 
response to these antigens was described, and mapped within the murine major histocom- 
patibility  (H-2)  complex  (3). On  the  other  hand,  the  primary IgM response to  these 
antigens has generally been thought not to be under genetic control. 
Mitchell et al. by using adult thymectomized, lethally irradiated,  and syngeneic bone 
marrow reconstituted high and low responder mice immunized with (T,G)-A-L without 
adjuvant found the primary IgM response to be T-independent and not under genetic 
control, while the secondary IgG response was noted to be both T-dependent and geneti- 
cally  controlled  (4). However,  experiments  involving  adoptively transferred  animals 
reconstituted with bone marrow cells and either antigen-primed thymocytes or antigen- 
specific T-helper factors implied that there was H-2-1inked genetic control of the IgM 
response to (T,G)-A-L (5). 
The  ability  to  define  more  precisely  the  nature  and  function  of immune 
response (Ir) genes has been limited by the relative lack of in vitro systems for 
analysis of genetic control and cellular requirements in the antibody response to 
synthetic polypeptides. Recently, an in vitro system was described for generat- 
ing a  true primary anti-hapten  response to trinitrophenyl  (TNP) conjugates of 
(T,G)-A-L  [TNP-(T,G)-A-L]  and  keyhole  limpet  hemocyanin  (TNP-KLH) 
which  was T-cell and  macrophage-dependent. 2 In the  present report the  ques- 
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tion  of whether  there  is  genetic  control  of the  primary  IgM  response  was 
examined utilizing this in vitro system. The primary IgM anti-TNP responses to 
both TNP-(T,G)-A-L and TNP-(H,G)-A-L were shown to be T-dependent and 
under autosomal dominant genetic control which was linked to the H-2 complex 
and mapped to the K  and I-A regions. In contrast,  the response to TNP-KLH, 
while T-dependent,  was not under demonstrable genetic control. 
Materials  and  Methods 
Animals.  C57BL/10 (B10), B10.A, BI0.BR, B10.D2, A/J, A.BY, C3H/HeJ,  C3H.SW, and (B10 
x  B10.A)F~  male  mice  were  obtained  from  The  Jackson  Laboratory,  Bar  Harbor,  Maine. 
B10.A(4R), B10.A(5R), and (A/J x  A.BY)F1 male mice were kindly provided by Dr. David Sachs, 
National  Institutes  of Health,  Betheeda,  Md.  All  mice  were  used  at  6-12  wk  of age  in  all 
experiments.  Pools of spleen cells from at least three syngeneic mice were used in each experi- 
ment. 
Antigens.  (T,G)-A-L was obtained from Yeda Research and Development Co., Ltd., Rehovot, 
Israel (lot number MC-3, mol wt 260,000).  (H,G)-A-L was the generous gift of Dr. Edna Mozes, 
Weizmann Institute, Rehovot, Israel.  KLH  (lot number 530195)  was obtained from Calbiochem, 
San Diego, Calif. 
TNP  Conjugation.  Antigens  were  conjugated  with  2,4,6-trinitrobenzene-sulfonate  (TNBS) 
(Pierce Chemical Co., Rockford, Ill.) as previously described. 2 The degree of TNP modification of 
the antigens used was eight TNP groups per 100,000 daltons (T,G)-A- L unless otherwise stated, 5 
TNP groups per 100,000 daltons (H,G)-A-L, 12 TNP groups per 100,000 daltons KLH, and 35 TNP 
groups per molecule bovine serum  albumin.  Sheep erythrocytes  (SRBC)  were  conjugated with 
TNP (TNP-SRBC) by the method of Rittenberg and Pratt (6). 
Cell Preparations and Culture Conditions.  The preparation of cell suspensions and the evalua- 
tion  of cell  surface  markers  were  as  described  elsewhere. 2 Preparation  of a  T-cell-enriched 
population  (T cells) was accomplished by nylon wool  column passage.  Preparation of a  T-cell- 
depleted population (B cells) was accomplished by the use of a  T-cell-specific rabbit anti-mouse 
brain serum (RaMB)  +  complement (C). 
Culture conditions used have also been described elsewhere, s Briefly, 5  ×  105 spleen cells (or 
cell mixtures where specified) were cultured with indicated concentrations of TNP-(T,G)-A-L, 
TNP-(H,G)-A- L, TNP-KLH or no antigen in a total vol of 200 ~1 per fiat bottom well of microtiter 
plates.  Two or three microtiter wells were  used per culture  group,  and replicate groups were 
employed as indicated. Cultures were incubated at 37°C in a  5% CO~-humidified air atmosphere. 
Cultures were harvested on day 4 unless otherwise specified. 
Hemolytic Plaque-Forming Cells (PFC) Assay.  Direct PFC were assayed on TNP-SRBC by the 
slide  modification  (7)  of the  Jerne  hemolytic  plaque  technique  (8).  Every  culture  group  was 
assayed in the presence and absence of TNP-BSA  (5  ×  10  -4  M  final concentration of TNP)  to 
determine the number of TNP-inhibitable PFC/107 cultured cells. Virtually all (>90%) direct PFC 
have been shown to be producing IgM antibody by inhibition with a  specific goat anti-mouse /~- 
serum  (6),  which was kindly provided by Dr.  Richard Asofsky,  National Institutes of Health, 
Bethesda, Md. IgG PFC were determined by first blocking IgM PFC with a  1:250 dilution of goat 
anti-mouse/~-serum and then developing the IgG PFC with a  1:100 dilution of a pool of a  specific 
rabbit anti-mouse 71" and y2-serum, which was also the generous gift of Dr.  Richard Asofsky. 
Results 
In Vitro Responses of  Normal BIO and BIO.A Spleen Cells to TNP-(T,G)-A - 
L and TNP-(H,G)-A -L.  The primary IgM anti-TNP PFC responses of normal 
B10  and  B10.A  spleen  cells  to  TNP-(T,G)-A-L  and  TNP-(H,G)-A-L  were 
examined (Table I). The response of spleen cells from normal B10 donors to TNP- 
(T,G)-A-L  is  dependent  upon  the  concentration  of TNP-(T,G)-A-L  in  the 
cultures.  An optimal response was detected at a  final concentration of 250  ~g/ 
ml, although there was a broad range in which a significant response above the 
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TABLE  I 
Response of BlO and BIO.A Spleen Cell to Various 
Concentrations of TNP-(T,G)-A -  L  and TNP-(H,G)-A -  L 
TNP-(T,G)-A - L 
Direct PFC/10' cultured cells* 
B10  B10.A 
ug/ml 
0  34 (1.40)  44 (1.64) 
10  218 (1.89)  28 (1.43) 
100  413 (1.19)  43 (1.61) 
250  1,391 (1.30)  45 (1.66) 
500  783 (1.29)  66 (1.84) 
Direct PFC/107 cultured cells$ 
TNP-(H,G)-A-  L 
~g/rnl  B10  B10.A 
0  36 (1.37)  35 (1.36) 
5  0  260 
50  69 (2.4)  430 (1.34) 
250  57 (1.9)  920 {1.41) 
500  80 (2.03)  517 (1.92) 
* Geometric  mean  (SE) of TNP-inhibitable  PFC  of five  individual 
spleens over two experiments. 
$ Geometric  mean  (SE) of TNPoinhibitable  PFC  of five  consecutive 
experiments, each consisting of pools of three spleens, except at 5 ~g/ 
ml which was performed in one experiment. 
cells to TNP-(T,G)-A-L  was not different from the no antigen control at any of 
the doses tested. The reciprocal strain pattern of responsiveness was observed to 
TNP-(H,G)-A-L.  Normal  B10.A  spleen  cells  responded  to  TNP-(H,G)-A-L 
with the  optimal response also detected at a  final concentration  of 250  ~tg/ml. 
Normal B10 spleen cells, however, did not significantly respond above control at 
any of the doses tested, although there was a  suggestion of a  small, though not 
statistically significant,  response at the highest dose of 500  ~g/ml. 
The observations that B10 spleen cells responded to TNP-(T,G)-A-L  but not 
TNP-(H,G)-A-L  while  B10.A  spleen  cells responded  to TNP-(H,G)-A-L  but 
not TNP-(T,G)-A-L  could be interpreted  as  indicating  either that:  (a) the  in 
vitro primary IgM PFC response is under the control of one or more H-2-1inked 
Ir genes; or (b) the differences are due to other factors introduced by the in vitro 
culture system. A number of experiments were performed to examine the latter 
possibility. 
One possibility was that the culture  conditions  required  to elicit a  response 
from B10.A  spleen  cells were  different  from the  conditions  necessary  for B10 
spleen cells.  Therefore, the in vitro conditions for obtaining a  response of both 
normal B10 and normal B10.A spleen cells to a  third  antigen,  TNP-KLH were 
determined.  The conditions for obtaining peak responses to TNP-KLH by both 
strains,  indeed by all strains studied,  were identical and occurred on day 4 at a 
dose of 10  ~g/ml (Table II and Table V). 
Another  possibility was  that  B10.A  spleen cells did not  survive well  under 
these  culture  conditions  in  the  presence  of TNP-(T,G)-A-L.  Therefore,  the A.  SINGER,  H.  B.  DICKLER,  AND  R.  J.  HODES 
TABLE  II 
Similar Responses  of Normal BIO and BIO •  Spleen Cells to 
Various Concentrations  of TNP-KLH 
TNP-KLH 
Direct PFC/IO ~ cultured cells* 
B10  B10.A 
~Lg/ml 
0  0  40 
0.1  80  480 
1  2,080  1,920 
10  4,360  9,240 
100  2,000  2,360 
* TNP-inhibitable PFC  response of a  pool  of three replicate  cultures 
after 4 days in culture. 
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TABLE III 
Percent  Viable Cell Recovery of BlO and BIO.A Spleen Cells* 
Antigen  B10  B10.A 
O  43.1  _+  3.7  65.4  _+  0.6 
TNP-(T,G)-A-L~  59.6 -+ 7.2  62.6  -+  1.9 
TNP-KLH§  62.6  _+  1.1  61.0 +- 3.2 
* Arithmetic mean +_  SE of triplicate cultures harvested on day 4. 
250  pg/ml. 
§ 10/zg/ml. 
viability of B10 and B10.A spleen cells after 4 days in culture with TNP-(T,G)- 
A-L, TNP-KLH, and without antigen was examined (Table III). There were no 
differences in the percent recovery of viable cells, as measured by dye exclusion, 
between B10 and B10.A spleen cells either with or without antigen. 
It was also possible that the response of normal B10.A spleen cells to TNP- 
(T,G),A-L would appear later than that of normal B10  spleen cells.  As was 
shown recently,  2 the peak response of normal B10  spleen cells to TNP-(T,G)- 
A-L  occurred on day 4. There was no response of B10.A spleen cells to TNP- 
(T,G)-A-L as late as day 5.  Beyond day 5, the viability of spleen cells under 
these culture conditions were too poor to allow any meaningful determinations 
(data not shown). 
The apparent lack of responsiveness of B10 spleen cells to TNP-(H,G)-A-L 
and of B10.A spleen cells to TNP-(T,G)-A-L could conceivably have been due to 
the generation of IgG PFC which were not detected as direct plaques. However, 
when this possibility was examined, neither normal B10 nor B10.A spleen cells 
developed any detectable IgG anti-TNP PFCs to either TNP-(T,G)-A-L or TNP- 
(H,G)-A-L (data not shown). 
It was also possible that altering the number of TNP groups per molecule of 
(T,G)-A-L would reverse the unresponsiveness of B10.A spleen cells to TNP- 
(T,G)-A-L. TNP ratios of from one to eight TNP groups per 100,000 daltons of 
(T,G)-A-L were tested (Table IV). Higher ratios were not used to avoid altering 
the normal structure of the (T,G)-A-L molecule further. B10.A spleen cells did 
not significantly  respond to any of  the preparations tested while B10 spleen cells 1100  Ir  GENE  CONTROL  OF  PRIMARY  IgM  RESPONSES 
TABLE  IV 
Response of Normal BI O and BI O.A Spleen Cells to (T,G)-A -L 
Conjugated with Various Amounts of TNP 
Direct PFC/IO  7 cultured cells* 
TNPx-(T,G)-A-L$ 
B10  B10.A 
TNPI-(T,G)-A-L§  363 (1.3)  40 (2.0) 
TNP5-(T,G)-A-LII  1,585 (1.06)  28 (1.44) 
TNPs-(T,G)-A-Lll  727 (1.12)  2 (2.42) 
* Geometric mean (SE) of net TNP-inhibitable PFC of triplicate culture 
groups. 
Number of TNP groups per 100,000 daltens of (T,G)-A-L. 
§ 100 ~g/ml (optimal concentration for this preparation). 
][ 250 ~g/ml (optimal concentrations for these preparations). 
responded  to  all  of them,  although  the  magnitude  and  dose optimum  of the 
response were somewhat dependent upon the actual substitution ratio used. 
Since the response to these antigens has previously been shown to be T-cell 
dependent, 2 the unresponsiveness of normal B10 spleen cells to TNP-(H,G)-A- 
L and of normal B10.A spleen cells to TNP-(T,G)-A-L could conceivably have 
been overcome by altering  the ratio of T  cells and B  cells in culture.  Normal 
spleen cells were separated into a  T-cell-depleted population  (B cells) by pre- 
treatment with RaMB serum +  C and into a T-cell-enriched population (T cells) 
by passage over a  nylon wool column. There was little or no response to TNP- 
KLH, TNP-(T,G)-A-L, or TNP-(H,G)-A-L by either normal B10 B cells (0% T) 
or T cells (100% T) cultured alone (Fig. 1). The responses to TNP-KLH and TNP- 
(T,G)-A-L were reconstituted to at least the level of the unseparated spleen by 
the addition of graded numbers of syngeneic T cells. With the addition of more T 
cells and the consequent decline in the number of B cells and probably macro- 
phages  (since  the  total  cell  number  in  the  cultures  were held constant),  the 
response to TNP-(T,G)-A- L declined, as was discussed previously.  2 In contrast, 
the unresponsiveness of B10 B cells to TNP-(H,G)-A- L persisted regardless of 
the number ofT cells added. In the B10.A, there was also essentially no response 
to any of the antigens in the B cell (0% T) or T cell (100% T) populations cultured 
alone. The responses to both TNP-KLH and TNP-(H,G)-A-L were fully recon- 
stituted by the addition of graded numbers of syngeneic T cells.  On the other 
hand, a significant response to TNP°(T,G)-A-L was not detected at any of the T 
cell/B cell ratios examined. 
Thus, the in vitro primary IgM anti-TNP responses to TNP-(T,G)-A-L, TNP- 
(H,G)-A-L, and TNP-KLH were T-dependent. Furthermore, the unresponsive- 
ness of the appropriate nonresponder strain could not be reversed by altering the 
ratio of syngeneic T cells and B cells in culture. 
It  was  therefore  concluded  that  culture  conditions  were  very  unlikely  to 
account for the different responses of normal B10 and B10.A spleen cells to TNP- 
(T,G)-A-L and TNP-(H,G)-A-L. 
H-2  Linkage  of the  Primary  IgM Anti-TNP  Response  to  TNP.(T,G)-A-L 
and TNP-(H,G)-A -L.  The responsiveness of normal B10 spleen cells to TNP- 
(T,G)-A-L  but  not  TNP-(H,G)-A-L,  and  the  reciprocal  responsiveness  of 8  Ix:  'D 
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Fro. i.  Effect  of  various  numbers  of  syngeneic splenic  T cells  on  the  primary  IgM  response 
of normal  B10 and B10.A  splenic B  cells  to TNP-KLH  (O  O), TNP-(T,G)-A-L 
(O  O), and  TNP-(H,G)-A- L (A  A). All  responses are  expressed as  TNP-inhibitable 
PFC/10'-cultured cells.  Total cell  number was held constant at 5 x 105 cells/culture  and 
consisted  of  varying mixtures of  syngeneic T cells  (nylon nonadherent spleen cells)  and B 
cells  (RaMB + C-treated  spleen cells).  Percent  T cells  was  calculated  as ([number of  nylon 
nonadherent spleen cells]/5  x 105)  x 100.  Since the total  cell  number per culture  was held 
constant, increases in T-cell  number were accompanied by reciprocal  decreases in the 
number of  B cells  (and  probably  macrophages)  present in  each  culture.  Immunofluorescent 
studies  revealed the following  number of  T and B cells  in each  population: 
Percent RaMB +  Percent sIg  ÷ 
22  42 
0  69 
86  1.0 
BI0 whole spleen 
RaMB  + C-treated  (B  cells) 
Nylon  nonadherent  (T 
cells) 
B10.A whole spleen 
RaMB  + C-treated  (B  cells) 
Nylon  nonadherent  (T 
cells) 
29  59 
0  80 
93  1.5 
normal B10.A  spleen  cells  to  TNP-(H,G)-A - L but  not  TNP-(T,G)-A- L strongly 
suggested that the responses to these two antigens were genetically  controlled 
and linked to the 1-1-2  complex. To further  explore  this  point,  the responses to 
TNP-KLH, TNP-(T,G)-A- L, and  TNP-(H,G)-A- L by a variety  of  strains  with 
different  H-2 haplotypes and  different  backgrounds were determined (Table  V). 1102  Ir  GENE  CONTROL  OF  PRIMARY  IgM  RESPONSES 
TABLE  V 
The In Vitro Primary Anti-TNP IgM Response to TNP-(T,G)-A-L and TNP-(H,G)-A-L, 
but Not TNP-KLH, is H-2 Linked 
Direct PFC/107 cultured cells 
TNP-(T,G)-  TNP.(H,G)- 
H-2  Strain  No antigen*  TNP-KLH*  P  value§  A-L$  P  value  A-L*  P  value 
b  BI0  57 (1.68)  2,675 (1.19)  <0.01  675 (1.13)  <0.01  100 (2.0)  NS 
b  A.BY  36 (1.81)  2,100 (1.16)  <0.01  560 (1.17)  <0.01  20 (1.25)  NS 
b  C3H.SW  0  1,500 (1.25)  <0.01  660 (1.03)  <0.001  20 (1.44)  NS 
a  B10.A  0  2,575 (1.09)  <0.001  0  NS  525 (1.42)  <0.02 
a  A]J  25 (1.25)  3,920 (1.04)  <0.001  40 (1.68)  NS  760 (1.10)  <0.001 
b/a  (B10 x  B10.A)F~  0  1,400 (1.09)  <0.001  440 (1.07)  <0.001  520 (1.37)  <0.01 
a/b  (A/J × A.BY)F,  60 (1.78)  4,640 (1.10)  <0.001  680 (1.09)  <0.001  560 (1.32)  <0.01 
k  B10.BR  54 (1.44)  2,440 (1.07)  <0.001  80 (2.3)  NS  480 (1.45)  <0.02 
k  C3H  50 (1.58)  860 (1.20)  <0.01  40 (1.49)  NS  440 (1.04)  <0.001 
d  B10.D2  0  2,060 (1.06)  <0.001  240 (1.12)  <0.01  160 (1.10)  <0.01 
* Geometric mean (SE) of TNP-inhibitable PFC of parallel triplicate culture groups from a pool of three spleens. 
Geometric mean (SE) of net (above no antigen background) TNP-inhibitable  PFC of parallel triplicate culture groups. 
=  10 #g/ml, TNP-(T,G)-A-L  =  250 #g/ml, and TNP-(H,G)-A-L  ~  250 #g/ml. 
§ Significance above 0 as determined by two-tailed Student's t test (NS ~  not significant  P  >  0.05). 
TNP-KLH 
Strains with the H-2  b haplotype all responded to TNP-(T,G)-A-L but not to 
TNP-(H,G)-A- L, while the H-2  a and t-1-2  k strains responded to TNP-(H,G)-A- 
L but not to TNP-(T,G)-A-L. H-2 d spleen cells significantly responded to both 
antigens, although the response in each case was lower in magnitude than those 
of  the other responder haplotypes. The response was, therefore, H-2-1inked on at 
least the three backgrounds studied,  with the H-2 b and H-2 d haplotypes re- 
sponding to TNP-(T,G)-A-L and the H-2% H-2 k, and H-2 d haplotypes respond- 
ing to TNP-(H,G)-A- L. 
F1  hybrids between H-2 a and Ho2  b mice on both the a  and b  backgrounds 
responded to both TNP-(T,G)-A-L and TNP-(H,G)-A-L, which indicated the 
autosomal dominance of these H-2-1inked responses. 
In addition, the fact that all the strains responded to TNP-KLH but responded 
variably to  TNP-(T,G)-A-L and  TNP-(H,G)-A-L  showed that  the  genetic 
control exhibited was not simply for TNP. 
Mapping of the Ir Genes Controlling the Primary IgM Anti-TNP Responses to 
TNP-(T,G)-A-L  and  TNP-(H,G)-A-L.  By  determining the  responses  to 
TNP-(T,G)-A- L and TNP-(H,G)-A- L in the B10.A(5R) and the B10.A(4R), two 
recombinant strains between B10 and B10.A, the genes controlling responsive- 
ness to TNP-(T,G)-A-L and TNP-(H,G)-A-L could be further localized within 
the H-2 region to the H-2 a and H-2 b haplotypes. 
The B10.A(5R) recombination occurred between the I-B  and I-J subregions, 
while the B10.A(4R) recombination occurred between the I-A  and I-B  subre- 
gions (9). All strains tested again responded to TNP-KLH (Table VI). Both the 
B10 and the B10.A(5R) responded to TNP-(T,G)-A-L showing that the gene(s) 
in the H-2 b halotype controlling responsiveness to TNP-(T,G)-A-L lies to the 
left oftheI-J subregion. Since neither the B10.A nor the B10.A(4R) responded to 
TNP-(T,G)-A-L, the gene(s) could be further localized to the left of the I-B 
subregion, that is, within the K or I.A regions of the H-2 ~ responder haplotype. 
Neither the B10 nor the B10.A(5R) responded to TNP-(H,G)-A-L, localizing 
the gene(s) in the H-2 ~ responder haplotype for TNP-(H,G)-A-L to the left of 
the I-J subregion. Both the B10.A and B10.A (4R) responded to TNP-(H,G)-A- A.  SINGER,  H.  B.  DICKLER,  AND  R.  J.  HODES  1103 
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L, localizing the gene(s) controlling responsiveness to this antigen within the K 
or I-A regions of the H-2 a responder haplotype. 
Unfortunately,  no recombinant strains  exist between B10 and B10.A which 
allow further localization of these genes to either the K or I-A regions of the H-2 ~ 
and H-2 b haplotypes. 
Discussion 
The Ir-1 locus was described as controlling the secondary IgG responses to the 
random-branched chain polypeptides (T,G)-A- L, (H,G)-A -  L, and (Phe,G)-A - 
L (3). This locus was autosomal dominant and mapped within the H-2 complex. 
In contrast, the primary IgM response to these antigens is generally thought to 
be neither T-dependent nor under genetic control (4). The work presented here 
with  TNP  conjugates  of  (T,G)-A-L,  (H,G)-A-L,  and  KLH  in  an  in  vitro 
microculture system and assaying the primary IgM anti-hapten  PFC responses 
of normal spleen cells from a variety of strains,  demonstrated that the primary 
IgM response to these antigens was indeed T-dependent and, for TNP-(T,G)-A- 
L  and  TNP-(H,G)-A-L  but not TNP-KLH,  under  autosomal  dominant  H-2- 
linked Ir control which mapped within the K  or I-A regions of the H-2 complex. 
The different responses to TNP-(T,G)-A-L and TNP-(H,G)-A-L among the 
strains tested were due to differences in Ir genes and not due to factors intro- 
duced by the in vitro culture system since:  (a) each strain had the capability of 
responding in this culture system as shown by the fact that each responded to 
one or the other synthetic polypeptide and that all responded similarly to a third 
antigen, TNP-KLH; (b) the antigens were not selectively toxic since there were 
no  differences  in  viabilities  during  culture  among  the  strains,  either  in  the 
presence or absence of antigen;  (c) nonresponders did not respond even if left a 
longer time in culture, nor did they produce IgG antibody which would not have 
been  detected as direct  PFC,  and  (d)  the  unresponsiveness  of nonresponders 
could not be reversed despite variation of either the TNP/carrier  substitution 
ratio or of the relative ratio of T cells and B cells put into culture. 
The results of adoptive transfer  experiments  with thymectomized high  and 
low responder strains  immunized  with  (T,G)-A-L  in saline  conflict with the 
present results in that the primary IgM response was T-independent  and not 
genetically controlled (4). A possible explanation for this discrepancy may relate 
to the structure of (T,G)-A-L.  The T-dependence of the primary IgM response 
to the defined synthetic-branched chain copolymers (T-T-G-G)-A-L and (T-G- 
T-G)-A- L has been studied (10). The primary IgM response to (T-T-G-G)-A-L 
is T-dependent while the response to (T-G-T-G)-A- L is T-independent. It seems 
possible that different batches of the random copolymer (T,G)-A- L may vary in 
the relative dominance of the two sequences, resulting in differences in the T- 
dependence of the primary IgM responses observed. In support of this concept, it 
has also been recently reported that the in vivo primary IgM response to certain 
preparations  of (T,G)-A-L may be under genetic control while others are not 
(11).  The relative T-dependence of these different preparations was not exam- 
ined. 
Whether or not the Ir genes controlling the in vitro primary IgM anti-hapten 
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A-L  and anti-(H,G)-A-L  responses is unclear.  The genes controlling the in 
vitro primary responses must have at least some carrier specificity since some 
strains respond to TNP-(T,G)-A-L,  some to TNP-(H,G)-A-L,  and all respond 
to  TNP-KLH.  The  genes  resemble  one  another  in  that  they  are  autosomal 
dominant, they map identically within the H-2 complex, and they have identical 
responder and nonresponder haplotypes, so far as has been tested. 
The in vitro studies described in this present report clearly demonstrated that 
the primary IgM response can be T-dependent and under Ir gene control. Thus, 
it is concluded that while Ir genes may function in the switch from specific IgM 
to IgG production as has been proposed (12), the same or other Ir genes can also 
govern the ability to generate an IgM response upon initial exposure to antigen. 
Similarly,  genetic control  of the in  vivo primary IgM response to Glu  ~6 Lys  ~5 
Phe  ~ has recently been reported  (13).  The present results further suggest that 
the  primary  IgM  responses  to  antigens  such  as  TNP-(T,G)-A-L  and  TNP- 
(H, G)-A-L are under Ir gene control when such responses are T-dependent. 
Two other in vitro systems in which responses to soluble synthetic polypep- 
tides are observed have been described. Both the primary and secondary in vitro 
responses to the linear copolymer Glu  6° Ala  3° Tyr  1° are genetically controlled, 
but both result in only IgG production (14). The other system involves the use of 
a  two  stage  Marbrook-Diener  culture  system,  the  first to  educate  T  cells  to 
(T,G)-A- L and the second to assay the ability of these (T,G)-A- L-educated T 
cells to help in the anti-DNP response to DNP-(T,G)-A-L (15). In contast to the 
results presented in this report, the anti-DNP response in this system was not 
under  genetic control  (16).  The  possible explanations  for this  discrepancy in- 
clude the requirement for educated rather han normal T cells as helper cells, the 
use of a  different preparation  of (T,G)-A-L,  or differences in  the  method  of 
hapten  conjugation.  This  last  possibility  arises  since  2,4-dinitofluorobenzene 
which was the haptenating reagent used in the Marbrook-Diener culture system 
studies, can modify the tyrosine residues of (T,G)-A-L more extensively than 
TNBS, which was used in the present studies (17,  18). Experiments  are under 
way to examine these points. 
The genetically controlled in vitro responses described in this report require 
the interaction of subpopulations of normal spleen cells which are relatively well 
characterized  and  which  can  be distinguished  and  separated  by established 
methods. 2 Thus,  the  potential  exists for careful determination  of the  cellular 
levels  (among  macrophages,  T  cells,  and  B  cells)  at which Ir defects are  ex- 
pressed in nonresponder haplotypes. It is also possible that this system can be 
used as an in vitro assay for various antigen-specific and nonspecific helper and 
suppressor factors which may be involved in regulation of the immune response. 
Experiments in these areas are now in progess. 
Summary 
The  in  vitro  primary  IgM  anti-hapten  responses  to  trinitrophenyl  (TNP) 
conjugates  of poly-L-(Tyr,Glu)-poly-D,L-Ala- poly-L-Lys (T,G)-A- L  and  poly- 
L(His, Glu)-poly-D,L-Ala--poly-L-Lys (H,G)-A-L  were shown  to  be  T-cell  de- 
pendent  and  under  autosomal  dominant  H-2-1inked  Ir  gene  control  which 
mapped within the K  or/-A regions of the H-2 complex. The in vitro response to 1106  Ir  GENE  CONTROL  OF  PRIMARY  IgM  RESPONSES 
TNP-keyhole limpet hemocyanin,  while T-dependent, was not under demon- 
strable genetic control.  The genes governing the in vitro primary IgM anti- 
hapten responses to TNP-(T,G)-A-L  and TNP-(H,G)-A-L  resemble the Ir 
genes controlling the in  vivo secondary IgG responses to (T,G)-A-L and (H,G)- 
A-L  in that they are autosomal dominant, map  identically within the H-2 
complex,  and have  identical responder  and nonresponder haplotypes.  It is 
concluded  that  Ir  genes can  govern the  ability  to  generate an IgM response upon 
initial  exposure to antigen. 
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